Bifidobacterium lactis ameliorates AOM/DSS-induced inflammation, dysbiosis, and colonic precancerous lesions.
- 2025-03-21
- Applied microbiology and biotechnology 109(1)
- Yi-Lin Chan
- Jun-Cheng Liao
- Tsung-Lin Li
- Chang-Jer Wu
- Yi-Han Chiu
- PubMed: 40116950
- DOI: 10.1007/s00253-025-13445-x
- Low evidence
- Animal Study
both B. lactis P and B. lactis S could attenuate AOM/DSS-induced body weight loss and intestine damage, reduce aberrant crypt foci (ACF) and the formation of colonic polyps
- Effect
- Beneficial
- Effect size
- Large